|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Female Reproductive Tract |
Department of Obstetrics and Gynecology3
Department of Clinical Chemistry,4 Helsinki University Central Hospital, 00029 HUS, Finland
Department of Biological Sciences,5 Imperial College, London SW7 2AZ, United Kingdom
Department of Obstetrics and Gynecology,6 University of Hong Kong, Queen Mary Hospital, Hong Kong, China
Glycodelin is a glycoprotein produced in many glands, particularly those of reproductive tissues. It appears as different glycoforms in amniotic fluid (glycodelin-A) and seminal plasma (glycodelin-S), but only glycodelin-A inhibits gamete adhesion. In the present study, glycodelin from secretory-phase endometrium, first-trimester pregnancy decidua, and midtrimester amniotic fluid was studied with respect to physicochemical properties, including glycosylation patterns and inhibitory activity of sperm-egg binding. Purified glycodelins from all these sources were similar in isoelectric focusing and in lectin immunoassays using lectins from Wisteria floribunda and Sambucus nigra. Likewise, the glycodelins inhibited sperm-egg binding in a dose-dependent manner, as measured by hemizona-binding assay. However, subtle quantitative physicochemical and biological differences were found between glycodelins from different sources as well as within the same tissue/fluid between different individuals. Differences were most pronounced between endometrial glycodelins from nonpregnancy and first-trimester pregnancy. The glycan structures studied by fast-atom bombardment mass spectrometry of individual amniotic fluid glycodelin-A samples also showed interindividual quantitative differences. In conclusion, glycodelins from different female reproductive tract tissues and amniotic fluid share substantial similarity, allowing all of them to be called glycodelin-A. However, these glycodelins exhibit quantitative physicochemical and functional differences between different sources and individuals.
2 Correspondence: Riitta Koistinen, Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Biomedicum Helsinki, P.O. Box 700, Haartmaninkatu 8, 00029 HUS, Finland. FAX: 358 9 47171731; riitta.koistinen{at}hus.fi
This article has been cited by other articles:
![]() |
C.-L. Lee, P.-C. Pang, W. S. B. Yeung, B. Tissot, M. Panico, T. T. H. Lao, I. K. Chu, K.-F. Lee, M.-K. Chung, K. K. W. Lam, et al. Effects of Differential Glycosylation of Glycodelins on Lymphocyte Survival J. Biol. Chem., May 29, 2009; 284(22): 15084 - 15096. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Toth, K. Roth, C. Kunert-Keil, C. Scholz, S. Schulze, I. Mylonas, K. Friese, and U. Jeschke Glycodelin Protein and mRNA Is Downregulated in Human First Trimester Abortion and Partially Upregulated in Mole Pregnancy J. Histochem. Cytochem., May 1, 2008; 56(5): 477 - 485. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Seppala, H. Koistinen, R. Koistinen, P.C.N. Chiu, and W.S.B. Yeung Glycosylation related actions of glycodelin: gamete, cumulus cell, immune cell and clinical associations Hum. Reprod. Update, May 1, 2007; 13(3): 275 - 287. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lapid and N. Sharon Meet the multifunctional and sexy glycoforms of glycodelin Glycobiology, March 1, 2006; 16(3): 39R - 45R. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Horcajadas, A. Riesewijk, J. Polman, R. van Os, A. Pellicer, S. Mosselman, and C. Simon Effect of controlled ovarian hyperstimulation in IVF on endometrial gene expression profiles Mol. Hum. Reprod., March 1, 2005; 11(3): 195 - 205. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |